comparemela.com

Latest Breaking News On - Institutional trading of olema pharmaceuticals - Page 1 : comparemela.com

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Forecasted to Post FY2023 Earnings of ($2 46) Per Share

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities researchers at Lifesci Capital increased their FY2023 earnings estimates for Olema Pharmaceuticals in a note issued to investors on Monday, October 23rd. Lifesci Capital analyst S. Slutsky now anticipates that the company will post earnings per share of ($2.46) for the year, up from their prior […]

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Given Average Rating of Buy by Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have received an average recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have covered the stock in […]

Olema Pharmaceuticals (NASDAQ:OLMA) Rating Reiterated by Oppenheimer

Oppenheimer reaffirmed their outperform rating on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a $21.00 target price on the stock. Other research analysts have also recently issued research reports about the company. Capital One Financial increased their target price on […]

Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated by Analysts at Oppenheimer

Equities research analysts at Oppenheimer started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a research note issued to investors on Thursday, FlyOnTheWall reports. The brokerage set an “outperform” rating on the stock. Several other equities research analysts have also commented on OLMA. Lifesci Capital reiterated an “outperform” rating on shares […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.